icon
موقع حكومي رسمي تابع لحكومة المملكة العربية السعودية
icon الأربعاء 10 جمادى الأولى 1448هـ
نسخة تجريبية
icon
روابط المواقع الالكترونية الرسمية السعودية تنتهي بـ gov.sa

جميع روابط المواقع الرسمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .gov.sa

icon
المواقع الرسمية الآمنة تستخدم HTTPS

تحقق من أن الموقع يستخدم بروتوكول HTTPS

icon

مسجل لدى هيئة الحكومة الرقمية برقم :

20250831619
اقتراحات

قائمة الدراسات السريرية المسجلة على الادوية

عرض 111 - 120 من 518
عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
A Phase 3, single-arm, multicenter, multinational, open label,one-way crossover study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged ≥ 12 years with severe hemophilia A or B, with or without inhibitory antibodies to factor VIII or IX Sanofi Ongoing Fitusiran 3 EFC17574 King Faisal Specialist Hospital and Research Center (Riyadh) , King Abdulaziz University Hospital (Jeddah)
A single arm, multicentre observational study to evaluate effectiveness of pegcetacoplan under real world conditions in patients with paroxysmal nocturnal hemoglobinuria (PNH) COMPLETE Sobi - Swedish Orphan Biovitrum AG Ongoing pegcetacoplan (ASPAVELI) 4 Sobi.PEGCE King Faisal Specialist Hospital and Research Center (Jeddah),King Faisal Specialist Hospital and Research Center (Riyadh),King Faisal Specialist Hospital and Research Center (Madinah)
The Effect of Black Seeds (Nigella Sativa) on Prediabetic Overweight and Obese Adolescents Imam Abdulrhman bin Faisal university Ongoing Nigella sativa seeds 3 2230500005 Family and Community Medicine Center (Dammam)
A Randomized, Double Blinded, Comparative Observational Interventional Study to Assess The Safety And Immunogenicity Of Hepatitis B Vaccine In Newborns / Adolescents And Adults Six Months Post Vaccination Arab Company for Pharmaceutical products Ongoing EUVAX B VACCINE 4 HBV-001 King Fahad Medical City (Riyadh),General Medical Polyclinic (Jeddah) ,Dafa Special Polyclinic
Impact of using Zinc Oxide versus Moist Exposed Wound Ointment (MEBO) in treatment of second stage pressure ulcer: A randomized control clinical trial King Abdullah Medical City (Makkah) Ongoing MEBO and Zinc oxide topical 3 Version 5 King Abdullah Medical City (Makkah)
A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP) CLINUVEL EUROPE LIMITED Terminated Afamelanotide 2a CUV156 King Faisal Specialist Hospital and Research Center (Riyadh)
A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib Novartis Ongoing remibrutinib 3 CLOU064C123 King Faisal Specialist Hospital and Research Center (Jeddah) - King Abdulaziz Medical City NG (Jeddah) - King Abdulaziz Medical City NG (Riyadh)
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II KalVista Pharmaceuticals Ltd Ongoing Sebetralstat 3 KVD900-302 King Faisal Specialist Hospital and Research Center (Riyadh)
A prospective observational international study of cabozantinib tablets in combination with nivolumab as first-line treatment of advanced renal cell carcinoma in adults Ipsen Pharma Ongoing Cabozantinib 4 CLIN-60000 King Abdulaziz Medical City NG (Riyadh)
A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn’s Disease Janssen Research & Development LLC Ongoing Guselkumab 3 CNTO1959CRD3005 King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Saud Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)